Trials / Conditions / Adrenal Cortical Carcinoma

Adrenal Cortical Carcinoma

10 registered clinical trials studyying Adrenal Cortical Carcinoma — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer NCT07085572	Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia	Phase 2
Recruiting	Characterization of the Strasbourg Cohort of Patients With Adrenal Cortex Carcinoma NCT07335679	University Hospital, Strasbourg, France	—
Recruiting	Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cort NCT06831175	West China Hospital	Phase 2
Recruiting	Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic NCT06006013	Emory University	Phase 2
Recruiting	Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) NCT06141369	Shanghai Jiao Tong University School of Medicine	N/A
Recruiting	PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metast NCT05286814	National Cancer Institute (NCI)	Phase 2
Unknown	Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data NCT06229405	Seoul National University Hospital	—
Active Not Recruiting	Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wi NCT02867592	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013	National Cancer Institute (NCI)	Phase 2
Completed	A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Conti NCT00001339	National Cancer Institute (NCI)	Phase 2